-
公开(公告)号:US20240041497A1
公开(公告)日:2024-02-08
申请号:US18266639
申请日:2021-11-29
申请人: Wook-Cheol Kim , Sadami Tsutsumi , NITTO SEIKO CO., LTD. , KYOTO PREFECTURAL PUBLIC UNIVERSITY CORPORATION , NATIONAL UNIVERSITY CORPORATION UNIVERSITY OF TOYAMA
发明人: Masakazu Ishihara , Yoshimitsu Ueno , Tomoaki Murata , Yukito Otsuki , Yusuke Kobayashi , Yoshinobu Oka , Wook-Cheol Kim , Tetsuo Aida , Sadami Tsutsumi
CPC分类号: A61B17/58 , A61L31/022 , A61B2017/00004
摘要: To ensure that a biodegradable medical implement dissolves in vivo at an appropriate dissolution rate. The biodegradable medical implement of the present invention is formed of a magnesium material, and, at least in one transverse section, a layer of magnesium crystal grains in which a (0001) plane in a hexagonal crystal structure is oriented toward a surface side is continuous over an entire circumference.
-
公开(公告)号:US11732311B2
公开(公告)日:2023-08-22
申请号:US16906115
申请日:2020-06-19
发明人: Hideki Niimi , Shinya Otsuki , Isao Kitajima
摘要: The improved Tm mapping method using imperfect-match linear long quenching probes can accurately distinguish among and identify microorganisms at least at the genus level and often at the species level even in a real-time PCR instrument having measurement errors of Tm values between PCR tubes within ±0.5° C. Therefore, the Tm mapping method can be performed in almost all real-time PCR instruments and can identify unspecified infection-causing pathogenic microorganisms in about 4 hours after sample collection.
-
3.
公开(公告)号:US20220125403A1
公开(公告)日:2022-04-28
申请号:US17427989
申请日:2020-02-02
申请人: National University Corporation University of Toyama , GENERAL INCORPORATED ASSOCIATION MEDICAL INNOVATION CONSORTIUM
发明人: Hideyuki HASEGAWA
摘要: Provided is a technique for improving spatial resolution contrast of an ultrasonic tomogram compared with a method based on a coherence between echo signals. The present invention provides an ultrasonic tomogram generation method including: an estimation step SA100 of estimating noise in echo signals of M channels output from an ultrasonic probe, which receives echoes of ultrasonic waves emitted from M (being a natural number of 2 or more) ultrasonic transducers and outputs an echo signal, and calculating a weight coefficient for emphasizing an echo from a reception focus according to a signal-to-noise ratio in the echo signals of the M channels; and a generation step SA110 of generating a beamformer representing an ultrasonic tomogram from the echo signals of the M channels, using the weight coefficient calculated in the estimation step SA100.
-
公开(公告)号:US20210317503A1
公开(公告)日:2021-10-14
申请号:US17224957
申请日:2021-04-07
发明人: Shunsuke KAWABE , Yuichi UCHIHO , Hideyuki NODA , Hideki NIIMI , Atsushi MATSUI
摘要: Provided is a bacterium number measuring system comprising a database storing known bacterial growth patterns in advance and an analyzing part. The analyzing part has first cultures containing a bacterial liquid that contains a measurement target bacteria and second cultures being different from the first cultures and containing the bacterial liquid and an antimicrobial drug. The analyzing part performs bacterium number measurement which measures the number of bacteria in the first cultures on a culturing part where culturing has started in the first and second cultures. The analyzing part compares the bacterium number measurement result with the growth curves stored in the database and thereby determines a timing to perform MIC measurement which measures the number of bacteria in the second cultures to determine a minimum inhibitory concentration of the measurement target bacterium. The analyzing part performs the MIC measurement at the thus-determined timing.
-
5.
公开(公告)号:US20210283246A1
公开(公告)日:2021-09-16
申请号:US16972367
申请日:2019-06-06
发明人: Hisashi NARIMATSU , Kiyohiko ANGATA , Hiroyuki KAJI , Atsushi KUNO , Takashi SATO , Yasunori CHIBA , Akira TOGAYACHI , Hiroki SHIMIZU , Maki SOGABE , Takanori WAGATSUMA , Masashi MIZOKAMI , Masaaki KORENAGA , Kazuto TAJIRI , Tatsuhiko OZAWA
IPC分类号: A61K39/29 , C07K14/005 , C07K16/08 , G01N33/576 , A61P31/20
摘要: An examination system that recognizes a glycosylated antigen in Dane particles of hepatitis B virus (HBV) and a neutralizing antibody that recognizes the glycosylated antigen and that exhibits an infection-inhibiting activity. It was elucidated that Dane particles are associated with specific glycan structures, and this enabled the construction of a new detection system for infectious, i.e., nucleic acid-containing, hepatitis B virus particles and the provision of a neutralizing antibody that recognizes a glycosylated antigen and that exhibits an infection-inhibiting activity.
-
公开(公告)号:US10808302B2
公开(公告)日:2020-10-20
申请号:US15779971
申请日:2017-07-13
摘要: A magnesium alloy is provided that includes: 5.0 mass % or more and 15.0 mass % or less of Al; 2.5 mass % or more and 7.0 mass % or less of Sr; 0.05 mass % or more and less than 3.0 mass % of Ca; and 0.1 mass % or more and 0.6 mass % or less of Mn, with a remainder including Mg and inevitable impurities.
-
公开(公告)号:US10479836B2
公开(公告)日:2019-11-19
申请号:US15578864
申请日:2016-05-31
发明人: Masashi Ikutani , Kiyoshi Takatsu , Hiromi Ehara , Ikuko Fujino , Shinya Ogawa
IPC分类号: A61K39/395 , C07K16/28 , A61P9/12 , A61P11/00 , A61K39/00
摘要: The present invention relates to a therapeutic agent for pulmonary hypertension comprising an interleukin-5 receptor (hereinafter, abbreviated to “IL-5R”)-inhibiting compound and therapeutic method therefor. More specifically, the present invention relates to a therapeutic agent for pulmonary hypertension comprising an antibody or an antibody fragment capable of specifically binding to the extracellular region of IL-5R and a therapeutic method therefor.
-
公开(公告)号:US10416165B2
公开(公告)日:2019-09-17
申请号:US15751792
申请日:2016-08-10
发明人: Nobuyuki Kurosawa , Masaharu Isobe
IPC分类号: C07H21/02 , C07H21/04 , C07K16/00 , A61K39/00 , C07K14/00 , G01N33/577 , C07K16/18 , C12N1/02 , C12N15/09 , G01N33/53 , C07K16/40 , C12N5/12 , C12N9/50 , C12N11/14
摘要: A method for separating cells capable of producing target antigen-specific monoclonal antibodies (TASMAs) wherein a cell group including antibody-producing cells is immobilized using a reversible crosslinking agent having cell membrane-permeating properties. The immobilized cell group is subjected to cell membrane dissolution using a surface active agent; and the cell group is reacted with a labeling target antigen. In the stained cell group a that has reacted with the labeling target antigen is separated. A method to produce TASMAs by separating mRNA from the cell separated using the method; preparing cDNA and preparing antigen-specific monoclonal antibodies or fragments thereof from the prepared cDNA. Also provided are a method whereby at least one cell capable of producing TASMAs is separated and a method whereby said antibodies can be produced by using the separated cell. Threonine 18 phosphorylated p53 (pT18-p53) and threonine 68 phosphorylated CHK2 (pT68-CHK2) specific monoclonal antibodies are also disclosed.
-
公开(公告)号:US20180057860A1
公开(公告)日:2018-03-01
申请号:US15688473
申请日:2017-08-28
发明人: Homare Tabata , Hiroshi Minami , Hideki Niimi , Isao Kitajima , Tomohiro Ueno , Shiroh Hayashi , Masashi Mori
CPC分类号: C12Q1/689 , C12N9/1252 , C12P19/34 , C12Q1/68 , C12Q1/686 , C12Q1/6895 , C12Y207/07007
摘要: Disclosed is a thermostable DNA polymerase preparation which can illimitably reduce the risk of false positivity in the detection of a subject microorganism utilizing a gene amplification reaction and therefore enables the selective amplification of DNA for detecting the subject microorganism even when the amount of the subject microorganism is small and therefore the amount of DNA collected therefrom is extremely small, and can be produced at a reduced cost. Also disclosed is a method for quantifying or quantifying/identifying a subject organism to be detected rapidly, conveniently and with high sensitivity using the preparation of the present invention.
-
公开(公告)号:US09700572B2
公开(公告)日:2017-07-11
申请号:US14494637
申请日:2014-09-24
申请人: Kracie Pharma, Ltd. , NATIONAL CANCER CENTER , National University Corporation University of Toyama
发明人: Hiroyasu Esumi , Masafumi Ikeda , Chika Miyoshi , Shigetoshi Kadota , Toshiki Okubo , Satoshi Yomoda , Takafumi Fuse , Takanori Kawashima , Shigeki Chiba
IPC分类号: A61K31/7048 , A61K31/7034 , A61K31/341 , A61K31/365 , A61K36/28
CPC分类号: A61K31/7048 , A61K31/341 , A61K31/365 , A61K31/7034 , A61K36/28 , A61K2300/00
摘要: The present invention is intended to provide a novel anticancer agent which is effective to a cancer. After administering an agent prepared using burdock fruit extract to a pancreas cancer patient so that a dose of arctigenin was 100 mg or more per day, the tumor reducing effect was observed, and, in addition, lowering of tumor markers was confirmed. The present invention provides an anticancer agent containing arctigenin, wherein a dose of the arctigenin is 100 mg or more per day. In addition, the present invention provides the anticancer agent containing arctigenin and arctiin at a weight ratio of arctigenin/arctiin=0.7 to 1.3.
-
-
-
-
-
-
-
-
-